Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01LFC
|
|||
| Former ID |
DIB016822
|
|||
| Drug Name |
Mutant ras vaccine
|
|||
| Synonyms |
Mutant ras vaccine, NCI; Ras peptide vaccine, NCI; 13 mer ras peptide, NCI
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 2 | [1] | |
| Company |
National Cancer Institute
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | J Clin Oncol 30, 2012 (suppl, abstr 2577). | |||
| REF 2 | The immunological and clinical effects of mutated ras peptide vaccine in combination with IL-2, GM-CSF, or both in patients with solid tumors. J Transl Med. 2014 Feb 24;12:55. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.